Osaic Holdings
FHTX icon

Osaic Holdings’s Foghorn Therapeutics FHTX Stock Holding History

Osaic Holdings’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$24 Sell
5
-1,024
-100% -$5.62K ﹤0.01% 7710
2025
Q4 		$5.56K Buy
1,029
+21
+2% +$95 ﹤0.01% 6652
2025
Q3 		$5.1K Buy
1,008
+7
+0.7% +$37 ﹤0.01% 6737
2025
Q2 		$4.71K Buy
+1,001
New +$4.18K ﹤0.01% 6571
2023
Q4 		– Sell
-300
Closed -$1.5K – 7358
2023
Q3 		$1.5K Hold
300
– – ﹤0.01% 6721
2023
Q2 		$2.11K Hold
300
– – ﹤0.01% 6647
2023
Q1 		$1.86K Hold
300
– – ﹤0.01% 6745
2022
Q4 		$2K Hold
300
– – ﹤0.01% 6646
2022
Q3 		$3K Hold
300
– – ﹤0.01% 6612
2022
Q2 		$4K Hold
300
– – ﹤0.01% 6586
2022
Q1 		$5K Sell
300
-100
-25% -$1.37K ﹤0.01% 6471
2021
Q4 		$9K Sell
400
-350
-47% -$5.03K ﹤0.01% 6332
2021
Q3 		$10K Buy
+750
New +$8.3K ﹤0.01% 6183

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Osaic Holdings's FHTX Position: Q1 2026 in Review

Osaic Holdings reduced its Foghorn Therapeutics (FHTX) stake by 100% in Q1 2026, selling an estimated $5.62K and leaving 5 shares worth $24. The position accounts for ﹤0.01% of the portfolio, ranked #7710.

Osaic Holdings first reported a position in FHTX in Q3 2021 and has held it in 13 quarters since. The position peaked at $10K in Q3 2021. 105 funds tracked by Wall St. Rank hold FHTX as of Q1 2026.

  • Osaic Holdings held 5 shares of Foghorn Therapeutics worth $24 as of Q1 2026.
  • Osaic Holdings sold 1,024 Foghorn Therapeutics shares in Q1 2026, an estimated $5.62K.
  • Foghorn Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7710 holding.
  • Osaic Holdings first reported a position in Foghorn Therapeutics in Q3 2021 and has held it in 13 quarters since.
  • Osaic Holdings's Foghorn Therapeutics position peaked at $10K in Q3 2021.
  • 105 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.